ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

TTNP Titan Pharmaceuticals Inc

6.70
0.00 (0.00%)
Pre Mercado
Última actualización: 08:11:11
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Titan Pharmaceuticals Inc TTNP NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.00% 6.70 08:11:11
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
6.70
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
25/1/202415:33EDGAR2Form 8-K - Current report
25/1/202415:29GLOBETitan Pharmaceuticals Fully Compliant With NASDAQ Listing..
18/1/202415:59EDGAR2Form 8-K - Current report
08/1/202416:13EDGAR2Form 8-K - Current report
28/12/202315:30EDGAR2Form 8-K - Current report
28/12/202315:15GLOBETitan Pharmaceuticals Announces Reverse Stock Split and..
28/11/202315:47EDGAR2Form DEF 14A - Other definitive proxy statements
17/11/202315:03EDGAR2Form PRE 14A - Other preliminary proxy statements
15/11/202315:05EDGAR2Form 8-K - Current report
26/10/202315:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/10/202315:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/10/202315:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/10/202315:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/10/202315:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/10/202316:26EDGAR2Form S-8 - Securities to be offered to employees in employee..
23/10/202314:07EDGAR2Form 3 - Initial statement of beneficial ownership of..
16/10/202316:08EDGAR2Form 8-K - Current report
16/10/202315:37GLOBETitan Pharmaceuticals Announces Appointment of Dato' Seow..
04/10/202316:30EDGAR2Form SC 13D - General statement of acquisition of beneficial..
19/9/202315:41EDGAR2Form 8-K/A - Current report: [Amend]
18/9/202315:45EDGAR2Form 8-K - Current report
18/9/202306:30GLOBETitan Pharmaceuticals Announces $9.5 Million Private..
08/9/202316:30EDGAR2Form 8-K - Current report
30/8/202315:28EDGAR2Form 8-K - Current report
14/8/202316:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/7/202319:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/7/202318:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/7/202318:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/7/202316:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/7/202316:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/7/202316:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/7/202316:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/7/202306:30GLOBETitan Pharmaceuticals Announces Sale of Certain ProNeura..
20/7/202320:57EDGAR2Form SC 13D - General statement of acquisition of beneficial..
07/7/202309:28EDGAR2Form 8-K - Current report
29/6/202315:15EDGAR2Form 8-K - Current report

Su Consulta Reciente

Delayed Upgrade Clock